236 related articles for article (PubMed ID: 23419703)
1. Aberrant TIRAP and MyD88 expression in B-cell chronic lymphocytic leukemia.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2013 Jun; 51(1):48-55. PubMed ID: 23419703
[TBL] [Abstract][Full Text] [Related]
2. TLR2 may influence the behavior of the malignant clone in B-CLL.
Antosz H; Sajewicz J; Marzec-Kotarska B; Dmoszyńska A; Baszak J; Jargiełło-Baszak M
Blood Cells Mol Dis; 2012 Jun; 49(1):32-40. PubMed ID: 22521894
[TBL] [Abstract][Full Text] [Related]
3. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
4. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
5. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
6. A unique feature of Toll/IL-1 receptor domain-containing adaptor protein is partially responsible for lipopolysaccharide insensitivity in zebrafish with a highly conserved function of MyD88.
Liu Y; Li M; Fan S; Lin Y; Lin B; Luo F; Zhang C; Chen S; Li Y; Xu A
J Immunol; 2010 Sep; 185(6):3391-400. PubMed ID: 20702732
[TBL] [Abstract][Full Text] [Related]
7. Different expression of CD180, CD284 and CD14 receptors on the CD19+ subpopulation of normal and B-CLL lymphocytes.
Antosz H; Sajewicz J; Marzec-Kotarska B; Kocki J; Dmoszyńska A
Folia Histochem Cytobiol; 2009; 47(4):593-8. PubMed ID: 20430725
[TBL] [Abstract][Full Text] [Related]
8. Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression.
Sampaio NG; Kocan M; Schofield L; Pfleger KDG; Eriksson EM
PLoS One; 2018; 13(8):e0202408. PubMed ID: 30138457
[TBL] [Abstract][Full Text] [Related]
9. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
[TBL] [Abstract][Full Text] [Related]
10. TIRAP: an adapter molecule in the Toll signaling pathway.
Horng T; Barton GM; Medzhitov R
Nat Immunol; 2001 Sep; 2(9):835-41. PubMed ID: 11526399
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
[TBL] [Abstract][Full Text] [Related]
12. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis.
Sacre SM; Andreakos E; Kiriakidis S; Amjadi P; Lundberg A; Giddins G; Feldmann M; Brennan F; Foxwell BM
Am J Pathol; 2007 Feb; 170(2):518-25. PubMed ID: 17255320
[TBL] [Abstract][Full Text] [Related]
13. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
14. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
15. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
16. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
[TBL] [Abstract][Full Text] [Related]
17. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
[TBL] [Abstract][Full Text] [Related]
18. MyD88 adaptor-like D96N is a naturally occurring loss-of-function variant of TIRAP.
George J; Kubarenko AV; Rautanen A; Mills TC; Colak E; Kempf T; Hill AV; Nieters A; Weber AN
J Immunol; 2010 Mar; 184(6):3025-32. PubMed ID: 20164415
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
20. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
